Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Short Communication
Authors: Clark, Alexandra L.a; * | Haley, Andreana P.a | Duarte, Audreya | O’Bryant, Sidb; c | for the Health and Aging Brain Study – Health Disparities (HABS-HD) Study Team1
Affiliations: [a] Department of Psychology, The University of Texas at Austin, Austin, TX, USA | [b] Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX, USA | [c] Department of Family Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA
Correspondence: [*] Correspondence to: Alexandra L. Clark, PhD, 108 East Dean Keeton, SEA 3.234, Austin, TX 78712, USA. Tel.: +1 512 471 1157; E-mail: Alexandra.Clark@austin.utexas.edu.
Note: [1] Data used in preparation of this article were obtained from the HABS-HD database (https://apps.unthsc.edu/itr/researchers). Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under Award Numbers R01AG054073 and R01AG058533. The consent is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Abstract: We examined ethnoracial differences in fatty acid binding protein (FABP)—a family of intracellular lipid carriers—and clarified FABP3 associations with gray and white matter. Relative to Mexican Americans (MAs), FABP3 was higher in Non-Hispanic Whites (NHWS, p < 0.001). Regressions revealed, independent of traditional AD markers, FABP3 was associated with neurodegeneration (B = –0.08, p = 0.003) and WMH burden (B = 0.18, p = 0.03) in MAs, but not in NHWs (ps > 0.18). Findings suggest FABP3 is related to neural health within MAs and highlight its potential as a prognostic marker of brain health in ethnoracially diverse older adults.
Keywords: Alzheimer’s disease, FABP3, Hispanic/Latino, lipid dyshomeostasis, mild cognitive impairment
DOI: 10.3233/JAD-220524
Journal: Journal of Alzheimer's Disease, vol. 90, no. 1, pp. 61-68, 2022
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl